Residents may petition the Department to add debilitating
medical conditions to those listed in Section 10(h) of the Act and Section
946.20. The Department will
accept petitions annually. The annual petition period for accepting petitions
will be for a one-month period from January 1 through January 31 each year.
Petitions received outside of the open periods specified in this Section will
not be reviewed and will be returned to the resident submitting the
petition.
a)
During the open
period, the Department will accept petitions from any resident requesting the
addition of a new debilitating medical condition or disease to the list of
approved debilitating medical conditions for which the use of cannabis has been
shown to have a therapeutic or palliative effect. The Department shall provide
public notice 30 days before the open period for accepting petitions, which
shall describe the time period for submission, the required format of the
submission, and the submission address, which is set forth in Section
946.205. (Section 45(b) of the
Act)
b)
Each petition shall
be limited to one proposed debilitating medical condition or disease.
(Section 45(c) of the Act)
c)
A petitioner shall file one original petition in the format provided by
the Department and in the manner specified by the Department. For a petition to
be processed and reviewed, the following information shall be
included: (Section 45(d) of the Act)
1)
A specific description of the
medical condition or disease that is the subject of the petition. The
petitioner shall not submit broad categories, e.g., all mental illnesses. Each
petition shall be limited to a single condition or disease. Information about
the proposed condition or disease shall include:
A)
The extent to which the condition
or disease itself and/or the treatments cause severe suffering, such as severe
and/or chronic pain, severe nausea and/or vomiting, or otherwise severely
impair a person's ability to carry on with activities of daily
living;
B)
Information about why conventional medical therapies are not sufficient
to alleviate the suffering caused by the disease or condition and its
treatment;
C)
The
proposed benefits from the medical use of cannabis specific to the medical
condition or disease;
D)
Evidence from the medical community and other experts supporting the
use of medical cannabis to alleviate suffering caused by the condition or
disease and/or treatment;
E)
Letters of support from physicians
or other licensed health care providers knowledgeable about the condition or
disease, including, if feasible, a letter from a health care
professional with whom the petitioner has a bona-fide health care
professional-patient relationship;
F)
Any additional medical,
testimonial or scientific documentation; and
G)
An electronic copy of all
materials submitted.
2)
Upon receipt of a petition, the
Department shall determine whether the petition meets the standards for
submission and, if so, will accept the petition for further review; or whether
the petition does not meet the standards for submission and, if so, shall deny
the petition without further review.
3)
If the petition does not fulfill
the standards for submission, the petition shall be considered deficient. The
Department shall notify the petitioner, who may correct any deficiencies and
resubmit the petition during the next open period.
d) The petitioner may withdraw
their petition by submitting a written statement to the Department indicating
withdrawal.
e)
Upon review
of accepted petitions, the Director will consult with Department staff
to analyze the clinical and scientific merit of the petitions. This
consultation will occur before the Director renders a final decision
regarding the acceptance or denial of the proposed debilitating medical
conditions or diseases. (Section 45(f) of the Act) The Department's
analysis will be recorded in a format prescribed by the Department.
f)
The Department will approve or
deny a petition within 180 days after its submission. (Section 45(a)
of the Act)
g) All petitions to add
debilitating medical conditions submitted to the Department in January 2016
will be reviewed in accordance with the rules for the addition of debilitating
medical conditions in effect at the time of the submission.